Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 2, 2008 - Issue 3
Submit an article Journal homepage
492
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Mesalamine with MMX™ technology for the treatment of ulcerative colitis

Stefan Schreiber Professor of Medicine & Gastroenterology, Institute for Clinical Molecular Biology, Center for Conservative Medicine, Schittenhelmstr. 12, 24105, Kiel, Germany. [email protected]
,
Michael A Kamm Professor of Gastroenterology, St Vincent’s Hospital, Melbourne, Australia; and, Imperial College London, London, UK. [email protected]
&
Gary R Lichtenstein Professor of Medicine, Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, 3400 Spruce Street, 3rd Floor Ravdin Building, Philadelphia, PA 19104-4283, USA. [email protected]
Pages 299-314 | Published online: 10 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Antonio Tursi. (2009) Balsalazide in treating colonic diseases. Expert Opinion on Drug Metabolism & Toxicology 5:12, pages 1555-1563.
Read now

Articles from other publishers (6)

Anitha Sriram, Suma Tangirala, Srividya Atmakuri, Sajid Hoque, Sheela Modani, Saurabh Srivastava, Srushti Mahajan, Indrani Maji, Rahul Kumar, Dharmendra Khatri, Jitender Madan & Pankaj Kumar Singh. (2021) Budding Multi-matrix Technology—a Retrospective Approach, Deep Insights, and Future Perspectives. AAPS PharmSciTech 22:8.
Crossref
Pedro M. Veloso, Raul Machado & Clarisse Nobre. (2021) Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 89-103.
Crossref
Chu K Yao, Rebecca E Burgell, Kirstin M Taylor, Mark G Ward, Antony B Friedman, Jacqueline S Barrett, Jane G Muir & Peter R Gibson. (2020) Effects of fiber intake on intestinal pH, transit, and predicted oral mesalamine delivery in patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 36:6, pages 1580-1589.
Crossref
E. Merino Gallego, F. Gallardo Sánchez, A. Hernández Martínez, A. Pérez González, L. Miras Lucas, C. Heredia Carrasco & F.J. Gallego Rojo. (2017) Experiencia clínica en el tratamiento con mesalazina MMX en monoterapia en los pacientes con colitis ulcerosa. Enfermedad Inflamatoria Intestinal al Día 16:2, pages 45-50.
Crossref
Natalia Pedersen, Peter Thielsen, Lars Martinsen, Mette Bennedsen, Anne Haaber, Ebbe Langholz, Zsuzsanna Végh, Dana Duricova, Tine Jess, Sally Bell, Johan Burisch & Pia Munkholm. (2014) eHealth. Inflammatory Bowel Diseases 20:12, pages 2276-2285.
Crossref
Irene Sonu, Ming Valerie Lin, Wojciech Blonski & Gary R. Lichtenstein. (2010) Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 39:3, pages 559-599.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.